Liver transplantation for pediatric metabolic disease

Molecular Genetics and Metabolism

Volumn 111, Issue 4, 2014, Pages 418-427

  Mazariegos, George ^a,b   Shneider, Benjamin ^a   Burton, Barbara ^c   Fox, Ira J ^a,b,d   Hadzic, Nedim ^e   Kishnani, Priya ^f   Morton, D Holmes ^g   Mcintire, Sara ^a   Sokol, Ronald J ^h   Summar, Marshall ⁱ   White, Desiree ^j   Chavanon, Vincent ^k   Vockley, Jerry ^a,b,l  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g FRANKLIN AND MARSHALL COLLEGE   (United States)

^h University of Colorado Denver and Children s Hospital Colorado   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY   (United States)

^j WASHINGTON UNIVERSITY   (United States)

^k MOUNT SINAI HOSPITAL   (United States)

^l UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Amino aciduria; Hepatocyte transplant; Inborn errors of metabolism; Liver failure; Liver transplant; Organic acidemia

Indexed keywords

CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLYCOGEN STORAGE DISEASE; GRAFT DYSFUNCTION; HEPATOCYTE TRANSPLANTATION; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAPLE SYRUP URINE DISEASE; METABOLIC DISORDER; METHYLMALONIC ACIDEMIA; PHENYLKETONURIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; TREATMENT OUTCOME; UREA CYCLE DISORDER; CHILD; LIVER CELL; METABOLIC DISEASES; ORGANIZATION; TRANSPLANTATION;

CHILD; CONGRESSES AS TOPIC; HEPATOCYTES; HUMANS; LIVER TRANSPLANTATION; METABOLIC DISEASES; TREATMENT OUTCOME;

EID: 84897571890     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2014.01.006     Document Type: Conference Paper

References (112)

1. Fouquet V., Alves A., Branchereau S., Grabar S., Debray D., Jacquemin E., Devictor D., Durand P., Baujard C., Fabre M., Pariente D., Chardot C., Dousset B., Massault P.P., Bernard D., Houssin D., Bernard O., Gauthier F., Soubrane O. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl. 2005, 11:152-160.
2. Diem H.V., Evrard V., Vinh H.T., Sokal E.M., Janssen M., Otte J.B., Reding R. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. Transplantation 2003, 75:1692-1697.
3. Carceller A., Blanchard H., Alvarez F., St-Vil D., Bensoussan A.L., Di Lorenzo M. Past and future of biliary atresia. J. Pediatr. Surg. 2000, 35:717-720.
4. Shneider B.L., Vockley J., Mazariegos G.V. Trading places: liver transplantation as a treatment, not a cure, for metabolic liver disease. Liver Transplant. 2011, 17:628-630.
5. Morioka D., Kasahara M., Takada Y., Shirouzu Y., Taira K., Sakamoto S., Uryuhara K., Egawa H., Shimada H., Tanaka K. Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl. 2005, 11:1332-1342.
6. Hansen K., Horslen S. Metabolic liver disease in children. Liver Transpl. 2008, 14:713-733.
7. Hansen K., Horslen S. Metabolic liver disease in children. Liver Transpl. 2008, 14:391-411.
8. Kayler L.K., Merion R.M., Lee S., Sung R.S., Punch J.D., Rudich S.M., Turcotte J.G., Campbell D.A., Holmes R., Magee J.C. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr. Transplant. 2002, 6:295-300.
9. Kayler L.K., Rasmussen C.S., Dykstra D.M., Punch J.D., Rudich S.M., Magee J.C., Maraschio M.A., Arenas J.D., Campbell D.A., Merion R.M. Liver transplantation in children with metabolic disorders in the United States. Am. J. Transplant. 2003, 3:334-339.
10. Ng V.L., Fecteau A., Shepherd R., Magee J., Bucuvalas J., Alonso E., McDiarmid S., Cohen G., Anand R., G.Studies of Pediatric Liver Transplantation Research Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a North American multicenter registry. Pediatrics 2008, 122:e1128-e1135.
11. Stevenson T., Millan M.T., Wayman K., Berquist W.E., Sarwal M., Johnston E.E., Esquivel C.O., Enns G.M. Long-term outcome following pediatric liver transplantation for metabolic disorders. Pediatr. Transplant. 2010, 14:268-275.
12. Zhang K.Y., Tung B.Y., Kowdley K.V. Liver transplantation for metabolic liver diseases. Clin. Liver Dis. 2007, 11:265-281.
13. Arnon R., Kerkar N., Davis M.K., Anand R., Yin W., Gonzalez-Peralta R.P., S.R.Group Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience. Pediatr. Transplant. 2010, 14:796-805.
14. Vockley J. Metabolism as a complex genetic trait, a systems biology approach: implications for inborn errors of metabolism and clinical diseases. J. Inherit. Metab. Dis. 2008, 31:619-629.
15. Scriver C.R., Waters P.J. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet. 1999, 15:267-272.
16. Strauss K.A., Wardley B., Robinson D., Hendrickson C., Rider N.L., Puffenberger E.G., Shelmer D., Moser A.B., Morton D.H. Classical maple syrup urine disease and brain development: principles of management and formula design. Mol. Genet. Metab. 2010, 99:333-345.
17. Morton D.H., Strauss K.A., Robinson D.L., Puffenberger E.G., Kelley R.I. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics 2002, 109:999-1008.
18. Strauss K.A., Mazariegos G.V., Sindhi R., Squires R., Finegold D.N., Vockley G., Robinson D.L., Hendrickson C., Virji M., Cropcho L., Puffenberger E.G., McGhee W., Seward L.M., Morton D.H. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am. J. Transplant. 2006, 6:557-564.
19. Mazariegos G.V., Morton D.H., Sindhi R., Soltys K., Nayyar N., Bond G., Shellmer D., Shneider B., Vockley J., Strauss K.A. Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative united network for organ sharing experience. J. Pediatr. 2012, 160:116-121. (e111).
20. Shellmer D.A., DeVito Dabbs A., Dew M.A., Noll R.B., Feldman H., Strauss K.A., Morton D.H., Vockley J., Mazariegos G.V. Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series. Pediatr. Transplant. 2011, 15:58-64.
21. Badell I.R., Hanish S.I., Hughes C.B., Hewitt W.R., Chung R.T., Spivey J.R., Knechtle S.J. Domino liver transplantation in maple syrup urine disease: a case report and review of the literature. Transplant. Proc. 2013, 45:806-809.
22. Barshop B.A., Khanna A. Domino hepatic transplantation in maple syrup urine disease. N. Engl. J. Med. 2005, 353:2410-2411.
23. Khanna A., Hart M., Nyhan W.L., Hassanein T., Panyard-Davis J., Barshop B.A. Domino liver transplantation in maple syrup urine disease. Liver Transpl. 2006, 12:876-882.
24. Seminara J., Tuchman M., Krivitzky L., Krischer J., Lee H.S., Lemons C., Baumgartner M., Cederbaum S., Diaz G.A., Feigenbaum A., Gallagher R.C., Harding C.O., Kerr D.S., Lanpher B., Lee B., Lichter-Konecki U., McCandless S.E., Merritt J.L., Oster-Granite M.L., Seashore M.R., Stricker T., Summar M., Waisbren S., Yudkoff M., Batshaw M.L. Establishing a consortium for the study of rare diseases: the Urea Cycle Disorders Consortium. Mol. Genet. Metab. 2010, 100(Suppl. 1):S97-S105.
25. Haberle J., Boddaert N., Burlina A., Chakrapani A., Dixon M., Huemer M., Karall D., Martinelli D., Crespo P.S., Santer R., Servais A., Valayannopoulos V., Lindner M., Rubio V., Dionisi-Vici C. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet. J. Rare. Dis. 2012, 7:32.
26. Ah Mew N., Krivitzky L., McCarter R., Batshaw M., Tuchman M. Urea Cycle Disorders Consortium of the Rare Diseases Clinical Research, clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ. J. Pediatr. 2013, 162:324-329. (e321).
27. Lee W.S., Sokol R.J. Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology 2007, 45:1555-1565.
28. Lee W.S., Sokol R.J. Liver disease in mitochondrial disorders. Semin. Liver Dis. 2007, 27:259-273.
29. He M., Rutledge S., Kelly D., Palmer C., Murdoch G., Majumder N., Nicholls R., Pei Z., Watkins P.A., Vockley J. A new genetic disorder in mitochondrial fatty acid b-oxidation, ACAD9 deficiency. Am. J. Hum. Genet. 2007, 81:87-103.
30. Wang Y., Mohsen A.W., Mihalik S.J., Goetzman E.S., Vockley J. Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes. J. Biol. Chem. 2010, 285:29834-29841.
31. Sokal E.M., Sokol R., Cormier V., Lacaille F., McKiernan P., Van Spronsen F.J., Bernard O., Saudubray J.M. Liver transplantation in mitochondrial respiratory chain disorders. Eur. J. Pediatr. 1999, 158(Suppl. 2):S81-S84.
32. Vu T.H., Tanji K., Holve S.A., Bonilla E., Sokol R.J., Snyder R.D., Fiore S., Deutsch G.H., DiMauro S., De Vivo D. Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome?. Hepatology 2001, 34:116-120.
33. Lee W.S., Sokol R.J. Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes. J. Pediatr. 2013, 163:942-948.
34. Schara U., von Kleist-Retzow J.C., Lainka E., Gerner P., Pyle A., Smith P.M., Lochmuller H., Czermin B., Abicht A., Holinski-Feder E., Horvath R. Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations. J. Inherit. Metab. Dis. 2011, 34:197-201.
35. Sass J.O., Hofmann M., Skladal D., Mayatepek E., Schwahn B., Sperl W. Propionic acidemia revisited: a workshop report. Clin. Pediatr. (Phila) 2004, 43:837-843.
36. Deodato F., Boenzi S., Santorelli F.M., Dionisi-Vici C. Methylmalonic and propionic aciduria. Am. J. Med. Genet. C: Semin. Med. Genet. 2006, 142C:104-112.
37. Rosenblatt D.S. Vitamin B12 (Cbl)-responsive disorders. J. Nutr. Sci. Vitaminol. (Tokyo) 1992, 593-596. (Spec No).
38. Weisfeld-Adams J.D., Morrissey M.A., Kirmse B.M., Salveson B.R., Wasserstein M.P., McGuire P.J., Sunny S., Cohen-Pfeffer J.L., Yu C., Caggana M., Diaz G.A. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Mol. Genet. Metab. 2010, 99:116-123.
39. Nagao M., Tanaka T., Morii M., Wakai S., Horikawa R., Kasahara M. Improved neurologic prognosis for a patient with propionic acidemia who received early living donor liver transplantation. Mol. Genet. Metab. 2013, 108:25-29.
40. Yorifuji T., Kawai M., Mamada M., Kurokawa K., Egawa H., Shigematsu Y., Kohno Y., Tanaka K., Nakahata T. Living-donor liver transplantation for propionic acidaemia. J. Inherit. Metab. Dis. 2004, 27:205-210.
41. Vara R., Turner C., Mundy H., Heaton N.D., Rela M., Mieli-Vergani G., Champion M., Hadzic N. Liver transplantation for propionic acidemia in children. Liver Transpl. 2011, 17:661-667.
42. Kasahara M., Sakamoto S., Kanazawa H., Karaki C., Kakiuchi T., Shigeta T., Fukuda A., Kosaki R., Nakazawa A., Ishige M., Nagao M., Shigematsu Y., Yorifuji T., Naiki Y., Horikawa R. Living-donor liver transplantation for propionic acidemia. Pediatr. Transplant. 2012, 16:230-234.
43. Mew N.Ah., McCarter R., Daikhin Y., Nissim I., Yudkoff M., Tuchman M. N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia. Pediatrics 2010, 126:e208-e214.
44. Chandler R.J., Chandrasekaran S., Carrillo-Carrasco N., Senac J.S., Hofherr S.E., Barry M.A., Venditti C.P. Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. Hum. Gene Ther. 2011, 22:477-481.
45. Filippi L., Gozzini E., Fiorini P., Malvagia S., la Marca G., Donati M.A. N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatol. 2010, 97:286-290.
46. Grunert S.C., Mullerleile S., De Silva L., Barth M., Walter M., Walter K., Meissner T., Lindner M., Ensenauer R., Santer R., Bodamer O.A., Baumgartner M.R., Brunner-Krainz M., Karall D., Haase C., Knerr I., Marquardt T., Hennermann J.B., Steinfeld R., Beblo S., Koch H.G., Konstantopoulou V., Scholl-Burgi S., Van Teeffelen-Heithoff A., Suormala T., Sperl W., Kraus J.P., Superti-Furga A., Schwab K.O., Sass J.O. Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet. J. Rare. Dis. 2013, 8:6.
47. de Mattos A.M., Olyaei A.J., Bennett W.M. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am. J. Kidney Dis. 2000, 35:333-346.
48. Kishnani P.S., Austin S.L., Arn P., Bali D.S., Boney A., Case L.E., Chung W.K., Desai D.M., El-Gharbawy A., Haller R., Smit G.P., Smith A.D., Hobson-Webb L.D., Wechsler S.B., Weinstein D.A., Watson M.S. Glycogen storage disease type III diagnosis and management guidelines. Genet. Med. 2010, 12:446-463.
49. Koeberl D.D., Kishnani P.S., Chen Y.T. Glycogen storage disease types I and II: treatment updates. J. Inherit. Metab. Dis. 2007, 30:159-164.
50. Hicks J., Wartchow E., Mierau G. Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct. Pathol. 2011, 35:183-196.
51. Baertling F., Mayatepek E., Gerner P., Baba H.A., Franzel J., Schlune A., Meissner T. Liver cirrhosis in glycogen storage disease Ib. Mol. Genet. Metab. 2013, 108:198-200.
52. Manzia T.M., Angelico R., Toti L., Cillis A., Ciano P., Orlando G., Anselmo A., Angelico M., Tisone G. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case report. Transplant. Proc. 2011, 43:1181-1183.
53. Kido J., Nakamura K., Matsumoto S., Mitsubuchi H., Ohura T., Shigematsu Y., Yorifuji T., Kasahara M., Horikawa R., Endo F. Current status of hepatic glycogen storage disease in Japan: clinical manifestations, treatments and long-term outcomes. J. Hum. Genet. 2013, 58:285-292.
54. Maheshwari A., Rankin R., Segev D.L., Thuluvath P.J. Outcomes of liver transplantation for glycogen storage disease: a matched-control study and a review of literature. Clin. Transplant. 2012, 26:432-436.
55. Muraca M., Burlina A.B. Liver and liver cell transplantation for glycogen storage disease type IA. Acta Gastroenterol. Belg. 2005, 68:469-472.
56. Bhattacharya N., Heaton N., Rela M., Walter J.H., Lee P.J. The benefits of liver transplantation in glycogenosis type Ib. J. Inherit. Metab. Dis. 2004, 27:539-540.
57. Labrune P. Glycogen storage disease type I: indications for liver and/or kidney transplantation. Eur. J. Pediatr. 2002, 161(Suppl. 1):S53-S55.
58. Marega A., Fregonese C., Tulissi P., Vallone C., Gropuzzo M., Toniutto P.L., Baccarani U., Bresadola F., Toso F., Montanaro D. Preemptive liver-kidney transplantation in von Gierke disease: a case report. Transplant. Proc. 2011, 43:1196-1197.
59. Muraca M., Gerunda G., Neri D., Vilei M.T., Granato A., Feltracco P., Meroni M., Giron G., Burlina A.B. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002, 359:317-318.
60. Dhawan A., Mitry R.R., Hughes R.D. Hepatocyte transplantation for liver-based metabolic disorders. J. Inherit. Metab. Dis. 2006, 29:431-435.
61. Ribes-Koninckx C., Ibars E.P., Calzado Agrasot M.A., Bonora-Centelles A., Miquel B.P., Vila Carbo J.J., Aliaga E.D., Pallardo J.M., Gomez-Lechon M.J., Castell J.V. Clinical outcome of hepatocyte transplantation in four pediatric patients with inherited metabolic diseases. Cell Transplant. 2012, 21:2267-2282.
62. Kido J., Nakamura K., Matsumoto S., Mitsubuchi H., Ohura T., Shigematsu Y., Yorifuji T., Kasahara M., Horikawa R., Endo F. Current status of hepatic glycogen storage disease in Japan: clinical manifestations, treatments and long-term outcomes. J. Hum. Genet. 2013, 58:285-292.
63. Waisbren S.E., Noel K., Fahrbach K., Cella C., Frame D., Dorenbaum A., Levy H. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol. Genet. Metab. 2007, 92:63-70.
64. Waisbren S.E., Azen C. Cognitive and behavioral development in maternal phenylketonuria offspring. Pediatrics 2003, 112:1544-1547.
65. Christ S.E., Huijbregts S.C., de Sonneville L.M., White D.A. Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol. Genet. Metab. 2010, 99(Suppl. 1):S22-S32.
66. Koch R., Burton B., Hoganson G., Peterson R., Rhead W., Rouse B., Scott R., Wolff J., Stern A.M., Guttler F., Nelson M., de la Cruz F., Coldwell J., Erbe R., Geraghty M.T., Shear C., Thomas J., Azen C. Phenylketonuria in adulthood: a collaborative study. J. Inherit. Metab. Dis. 2002, 25:333-346.
67. Macdonald A., Rocha J.C., van Rijn M., Feillet F. Nutrition in phenylketonuria. Mol. Genet. Metab. 2011, 104(Suppl.):S10-S18.
68. Trefz F., Maillot F., Motzfeldt K., Schwarz M. Adult phenylketonuria outcome and management. Mol. Genet. Metab. 2011, 104(Suppl.):S26-S30.
69. Giovannini M., Verduci E., Salvatici E., Paci S., Riva E. Phenylketonuria: nutritional advances and challenges. Nutr. Metab. 2012, 9:7.
70. Burton B.K., Adams D.J., Grange D.K., Malone J.I., Jurecki E., Bausell H., Marra K.D., Sprietsma L., Swan K.T. Tetrahydrobiopterin therapy for phenylketonuria in infants and young children. J. Pediatr. 2011, 158:410-415.
71. Ding Z., Harding C.O., Thony B. State-of-the-art 2003 on PKU gene therapy. Mol. Genet. Metab. 2003, 81(2004):3-8.
72. Vajro P., Strisciuglio P., Houssin D., Huault G., Laurent J., Alvarez F., Bernard O. Correction of phenylketonuria after liver transplantation in a child with cirrhosis. N. Engl. J. Med. 1993, 329:363.
73. Harding C. Progress toward cell-directed therapy for phenylketonuria. Clin. Genet. 2008, 74:97-104.
74. Stephenne X., Debray F.G., Smets F., Jazouli N., Sana G., Tondreau T., Menten R., Goffette P., Boemer F., Schoos R., Gersting S.W., Najimi M., Muntau A.C., Goyens P., Sokal E.M. Hepatocyte transplantation using the domino concept in a child with tetrabiopterin nonresponsive phenylketonuria. Cell Transplant. 2012, 21:2765-2770.
75. Alexandrova K., Griesel C., Barthold M., Heuft H.G., Ott M., Winkler M., Schrem H., Manns M.P., Bredehorn T., Net M., Vidal M.M., Kafert-Kasting S., Arseniev L. Large-scale isolation of human hepatocytes for therapeutic application. Cell Transplant. 2005, 14:845-853.
76. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., Dorko K., Sauter B.V., Strom S.C. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 1998, 338:1422-1426.
77. Lee K.W., Lee J.H., Shin S.W., Kim S.J., Joh J.W., Lee D.H., Kim J.W., Park H.Y., Lee S.Y., Lee H.H., Park J.W., Kim S.Y., Yoon H.H., Jung D.H., Choe Y.H., Lee S.K. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant. 2007, 16:629-637.
78. Fitzpatrick E., Mitry R.R., Dhawan A. Human hepatocyte transplantation: state of the art. J. Intern. Med. 2009, 266:339-357.
79. Meyburg J., Das A.M., Hoerster F., Lindner M., Kriegbaum H., Engelmann G., Schmidt J., Ott M., Pettenazzo A., Luecke T., Bertram H., Hoffmann G.F., Burlina A. One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 2009, 87:636-641.
80. Meyburg J., Schmidt J., Hoffmann G.F. Liver cell transplantation in children. Clin. Transpl. 2009, 23(Suppl. 21):75-82.
81. Meyburg J., Hoffmann G.F. Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol. Genet. Metab. 2010, 100(Suppl. 1):S77-S83.
82. Guha C., Sharma A., Gupta S., Alfieri A., Gorla G.R., Gagandeep S., Sokhi R., Roy-Chowdhury N., Tanaka K.E., Vikram B., Roy-Chowdhury J. Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte. Transplant. Cancer Res. 1999, 59:5871-5874.
83. Sze Y.K., Dhawan A., Taylor R.M., Bansal S., Mieli-Vergani G., Rela M., Heaton N. Pediatric liver transplantation for metabolic liver disease: experience at King's College Hospital. Transplantation 2009, 87:87-93.
84. Lohlun J.C., Matas A.J., Chinnakotla S. Donor-specific human leukocyte antigen antibodies and late graft fibrosis after pediatric liver transplantation: time-associated variables or cause and effect?. Liver Transpl. 2012, 18:1270-1271.
85. Scheenstra R., Peeters P.M., Verkade H.J., Gouw A.S. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 2009, 49:880-886.
86. Magee J.C. Graft fibrosis in stable pediatric liver transplant recipients: what does it mean?. Hepatology 2009, 49:726-728.
87. Soltys K.A., Mazariegos G.V., Squires R.H., Sindhi R.K., Anand R., Group S.R. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am. J. Transplant. 2007, 7:2165-2171.
88. Ng V.L., Alonso E.M., Bucuvalas J.C., Cohen G., Limbers C.A., Varni J.W., Mazariegos G., Magee J., McDiarmid S.V., Anand R., G.Studies of Pediatric Liver Transplantation Research Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J. Pediatr. 2012, 160:820-826. (e823).
89. Organ Procurement and Transplantation Network, Policies., in: O.P.a.T. Network (Ed.).
90. McDiarmid S.V., Goodrich N.P., Harper A.M., Merion R.M. Liver transplantation for status 1: the consequences of good intentions. Liver Transplant. 2007, 13:699-707.
91. Soltys K.A., Soto-Gutierrez A., Nagaya M., Baskin K.M., Deutsch M., Ito R., Shneider B.L., Squires R., Vockley J., Guha C., Roy-Chowdhury J., Strom S.C., Platt J.L., Fox I.J. Barriers to the successful treatment of liver disease by hepatocyte transplantation. J. Hepatol. 2010, 53:769-774.
92. Saudubray J.M., Touati G., Delonlay P., Jouvet P., Schlenzig J., Narcy C., Laurent J., Rabier D., Kamoun P., Jan D., Revillon Y. Liver transplantation in propionic acidaemia. Eur. J. Pediatr. 1999, 158(Suppl. 2):S65-S69.
93. Schlenzig J.S., Poggi-Travert F., Laurent J., Rabier D., Jan D., Wendel U., Sewell A.C., Revillon Y., Kamoun P., Saudubray J.M. Liver transplantation in two cases of propionic acidaemia. J. Inherit. Metab. Dis. 1995, 18:448-461.
94. Kim T.W., Hall S.R. Liver transplantation for propionic acidaemia in a 14-month-old male. Paediatr. Anaesth. 2003, 13:554-556.
95. Barshes N.R., Vanatta J.M., Patel A.J., Carter B.A., O'Mahony C.A., Karpen S.J., Goss J.A. Evaluation and management of patients with propionic acidemia undergoing liver transplantation: a comprehensive review. Pediatr. Transplant. 2006, 10:773-781.
96. Burdelski M., Rodeck B., Latta A., Latta K., Brodehl J., Ringe B., Pichlmayr R. Treatment of inherited metabolic disorders by liver transplantation. J. Inherit. Metab. Dis. 1991, 14:604-618.
97. Morioka D., Kasahara M., Takada Y., Corrales J.P., Yoshizawa A., Sakamoto S., Taira K., Yoshitoshi E.Y., Egawa H., Shimada H., Tanaka K. Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am. J. Transplant. 2005, 5:2754-2763.
98. Yorifuji T., Muroi J., Uematsu A., Nakahata T., Egawa H., Tanaka K. Living-related liver transplantation for neonatal-onset propionic acidemia. J. Pediatr. 2000, 137:572-574.
99. Sato S., Kasahara M., Fukuda A., Mizuguchi K., Nakagawa S., Muguruma T., Saito O., Karaki C., Nakagawa A., Yoshii K., Horikawa R. Liver transplantation in a patient with propionic acidemia requiring extra corporeal membrane oxygenation during severe metabolic decompensation. Pediatr. Transplant. 2009, 13:790-793.
100. Romano S., Valayannopoulos V., Touati G., Jais J.P., Rabier D., de Keyzer Y., Bonnet D., de Lonlay P. Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J. Pediatr. 2010, 156:128-134.
101. Lehnert W., Sperl W., Suormala T., Baumgartner E.R. Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients. Eur. J. Pediatr. 1994, 153:S68-S80.
102. Manzoni D., Spotti A., Carrara B., Gritti P., Sonzogni V. Anaesthesia for liver transplantation in two infants with an organic acidaemia. Pediatr. Transplant. 2006, 10:623-628.
103. Nagarajan S., Enns G.M., Millan M.T., Winter S., Sarwal M.M. Management of methylmalonic acidaemia by combined liver-kidney transplantation. J. Inherit. Metab. Dis. 2005, 28:517-524.
104. Chakrapani A., Sivakumar P., McKiernan P.J., Leonard J.V. Metabolic stroke in methylmalonic acidemia five years after liver transplantation. J. Pediatr. 2002, 140:261-263.
105. van't Hoff W., McKiernan P.J., Surtees R.A., Leonard J.V. Liver transplantation for methylmalonic acidaemia. Eur. J. Pediatr. 1999, 158(Suppl. 2):S70-S74.
106. Nyhan W.L., Gargus J.J., Boyle K., Selby R., Koch R. Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver. Eur. J. Pediatr. 2002, 161:377-379.
107. Kaplan P., Mazur A., Smith R., Olthoff E., Maller M., Palmieri M., Berry G.T. Transplantation for maple syrup urine disease (MSUD) and methylmalonic acedemia (MMA). J. Inherit. Metab. Dis. 1997, (Supplement).
108. Goyens P., Brasseur D., Otte J., Marchau F., DeLaet C., Cavatorta E., Sokal E.M., Van Hoof F., Vie H. Liver transplantation for methylmalonyl-CoA mutase deficiency. J. Inherit. Metab. Dis. 1997, (Suppl. 1).
109. van't Hoff W.G., Dixon M., Taylor J., Mistry P., Rolles K., Rees L., Leonard J.V. Combined liver-kidney transplantation in methylmalonic acidemia. J. Pediatr. 1998, 132:1043-1044.
110. Hsui J.Y., Chien Y.H., Chu S.Y., Lu F.L., Chen H.L., Ho M.J., Lee P.H., Hwu W.L. Living-related liver transplantation for methylmalonic acidemia: report of one case. Acta Paediatr. Taiwan. 2003, 44:171-173.
111. Kasahara M., Horikawa R., Tagawa M., Uemoto S., Yokoyama S., Shibata Y., Kawano T., Kuroda T., Honna T., Tanaka K., Saeki M. Current role of liver transplantation for methylmalonic acidemia: a review of the literature. Pediatr. Transplant. 2006, 10:943-947.
112. Morioka D., Kasahara M., Horikawa R., Yokoyama S., Fukuda A., Nakagawa A. Efficacy of living donor liver transplantation for patients with methylmalonic acidemia. Am. J. Transplant. 2007, 7:2782-2787.